Header cover image
  • Investing Ideas
  • /
  • Palestinian Pharmaceuticals & Biotech Potentially Undervalued Companies

Palestinian Pharmaceuticals & Biotech Potentially Undervalued Companies

Results

1

0 new

Companies with a Value score of at least 3, ordered by Value score

1 companies

Jerusalem Pharmaceuticals

Market Cap: US$70.2m

Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.

JPH

US$3.90

7D

1.3%

1Y

6.6%